Company / Current Liabilities per Share
NewAmsterdam Pharma Co N.V. Current Liabilities per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.72
FY2025
5-year range
$0.61 / $1.90
FY2022-FY2025
Trend
-36.1%
vs FY2024
Sector context
#125 of 208
Health Care
What the data says
At $0.72, NewAmsterdam Pharma Co N.V.'s current liabilities per share ranks #84 of 208 in the Health Care sector. Increased from $0.61 to $0.72 over the past 2 years.
Based on SEC 10-K filings.
0.72 in FY2025 with a 3-year CAGR of -27.5%.
Increased from $0.61 to $0.72 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -27.5%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#84 of 208 in Health CareTop 40% of 208This company $0.72 Sector average $26.71
▼
-97.3% below sector average
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 36.1% year-over-year.
- Ranks #125 out of 208 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 3.01 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.72 | -36.1% |
| FY2024 | $1.13 | +86.6% |
| FY2023 | $0.61 | -68.1% |
| FY2022 | $1.90 | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026